Resverlogix Corp. (TSE:RVX – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.10 and traded as high as C$0.12. Resverlogix shares last traded at C$0.12, with a volume of 35,976 shares changing hands.
Resverlogix Stock Up 9.1%
The company has a current ratio of 0.05, a quick ratio of 0.04 and a debt-to-equity ratio of -15.77. The business’s 50-day simple moving average is C$0.10 and its 200-day simple moving average is C$0.10. The company has a market capitalization of C$34.48 million, a PE ratio of -4.00 and a beta of 0.70.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
